Back to Search
JACOB ACKERMANN, PHARMD
PHARMD
Pharmacist
NPI: 1962989350Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
20517(AL)
Research & Publications (20)
The fibroblast growth factor-2 is not essential for melanoma formation in a transgenic mouse model.
PMID 16029424·Pigment Cell Res·2005
7-preclinical
Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background.
PMID 15899789·Cancer Res·2005
7-preclinical
Dye-adsorption-induced gelation of suspensions of spherical and rodlike zinc oxide nanoparticles in organic solvents.
PMID 19301838·Langmuir·2009
8-other
Oxidosqualene cyclase from Saccharomyces cerevisiae, Trypanosoma cruzi, Pneumocystis carinii and Arabidopsis thaliana expressed in yeast: a model for the development of novel antiparasitic agents.
PMID 19119009·Bioorg Med Chem Lett·2009
7-preclinical
Petri net modelling of gene regulation of the Duchenne muscular dystrophy.
PMID 18372101·Biosystems·2008
7-preclinical
On-line monitoring of lipid storage in yeasts using impedance spectroscopy.
PMID 18395924·J Biotechnol·2008
8-other
Cytogenetic patterns in multiple myeloma after a phase of preceding MGUS.
PMID 18173551·Eur J Clin Invest·2008
4-observational
Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development.
PMID 18006687·Genes Dev·2007
7-preclinical
Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion.
PMID 17096015·Leukemia·2007
3-trial
Chromosomal abnormalities of young multiple myeloma patients (<45 yr) are not different from those of other age groups and are independent of stage according to the International Staging System.
PMID 17253972·Eur J Haematol·2007
8-other
Multimodality optical imaging and 18F-FDG uptake in wild-type p53-containing and p53-null human colon tumor xenografts.
PMID 17932466·Cancer Biol Ther·2007
7-preclinical
Bridging the gap: a dental access initiative for Northland children.
PMID 16568882·N Z Dent J·2006
8-other
Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors.
PMID 16213138·Bioorg Med Chem Lett·2005
7-preclinical
Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation.
PMID 16203765·Clin Cancer Res·2005
5-case
Design of selective phenylglycine amide tissue factor/factor VIIa inhibitors.
PMID 15664864·Bioorg Med Chem Lett·2005
8-other
Design of organic semiconductors: tuning the electronic properties of pi-conjugated oligothiophenes with the 3,4-ethylenedioxythiophene (EDOT) building block.
PMID 15832400·Chemistry·2005
8-other
Optimization and design of oligonucleotide setup for strand displacement amplification.
PMID 15975661·J Biochem Biophys Methods·2005
8-other
Alpha,omega-distyryl oligothiophenes: high mobility semiconductors for environmentally stable organic thin film transistors.
PMID 16305192·J Am Chem Soc·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12070 COUNTY LINE RD
MADISON, AL 35756 - Phone
- (256) 230-2626
Quick Facts
- NPI
- 1962989350
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile